Form 4: Integer Holdings Corp: CEO Joseph Dziedzic Reports Stock Transactions Following PSU Vesting

Integer Holdings Corp CEO Joseph Dziedzic reports acquisition and disposal of common stock following the vesting of performance-based restricted stock units (PSUs).

Summary

• Joseph W. Dziedzic, President & CEO of Integer Holdings Corp, reported transactions involving the company's common stock on February 21, 2025.
• These transactions include the acquisition of 42,002 shares and 45,970 shares of common stock, both at a price of $0, resulting from the vesting of performance-based restricted stock units (PSUs).
• The vesting of 42,002 PSUs was based on the satisfaction of 3-year relative total shareholder return goals.
• The vesting of 45,970 PSUs was based on the satisfaction of specified financial performance targets based upon organic sales growth achievement for each of 2022, 2023 and 2024.
• Dziedzic also reported the disposal of 34,618 shares of common stock at a price of $129.87.
• Following these transactions, Dziedzic beneficially owns 291,784 shares of Integer Holdings Corp common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports routine transactions related to executive compensation. The vesting of PSUs suggests the company is meeting its performance goals, which is mildly positive, but the sale of shares is a neutral event.

Positives

• The vesting of PSUs indicates that the company has met certain performance targets related to shareholder return and organic sales growth.

Negatives

• The disposal of 34,618 shares by the CEO could be interpreted negatively by some investors, although it is likely related to covering tax obligations associated with the vesting of the PSUs.

Industry Context

This filing is a routine disclosure of insider transactions and doesn't necessarily reflect broader industry trends. However, the vesting of PSUs based on performance metrics suggests a focus on shareholder value and organic growth, which are common goals in the medical device industry.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards like PSUs to align management's interests with those of shareholders.
• The specific metrics used (relative TSR and organic sales growth) are common performance indicators in the medical device industry, reflecting a focus on both market performance and revenue generation.
• Comparing Integer Holdings' performance against its peers in the medical device sector would provide further context on the significance of achieving these PSU vesting targets.

Stakeholder Impact

• The vesting of PSUs and subsequent stock transactions may have a minor impact on shareholders, potentially influencing the stock price in the short term.

Key Dates